HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport.
Hataf KhanRebecca P SumnerJane RasaiyaahChoon Ping TanMaria Teresa Rodriguez-PlataChris Van TullekenDouglas FinkLorena Zuliani-AlvarezLucy ThorneDavid StirlingRichard Sb MilneGreg J TowersPublished in: eLife (2020)
HIV-1 must replicate in cells that are equipped to defend themselves from infection through intracellular innate immune systems. HIV-1 evades innate immune sensing through encapsidated DNA synthesis and encodes accessory genes that antagonize specific antiviral effectors. Here, we show that both particle associated, and expressed HIV-1 Vpr, antagonize the stimulatory effect of a variety of pathogen associated molecular patterns by inhibiting IRF3 and NF-κB nuclear transport. Phosphorylation of IRF3 at S396, but not S386, was also inhibited. We propose that, rather than promoting HIV-1 nuclear import, Vpr interacts with karyopherins to disturb their import of IRF3 and NF-κB to promote replication in macrophages. Concordantly, we demonstrate Vpr-dependent rescue of HIV-1 replication in human macrophages from inhibition by cGAMP, the product of activated cGAS. We propose a model that unifies Vpr manipulation of nuclear import and inhibition of innate immune activation to promote HIV-1 replication and transmission.
Keyphrases
- innate immune
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- men who have sex with men
- signaling pathway
- south africa
- dendritic cells
- oxidative stress
- induced apoptosis
- gene expression
- pi k akt
- lps induced
- single molecule
- endoplasmic reticulum stress
- transcription factor
- binding protein
- cell free
- circulating tumor
- genome wide analysis